Catherine Y. Spong
Section on Developmental and Molecular Pharmacology
LDN, NICHD
NIH, Bethesda
USA
Name/email consistency: high
- Vasoactive intestinal peptide mRNA and immunoreactivity are decreased in fetal alcohol syndrome model. Spong, C.Y., Auth, J., Vink, J., Goodwin, K., Abebe, D.T., Hill, J.M., Brenneman, D.E. Regul. Pept. (2002)
- Prevention of fetal demise and growth restriction in a mouse model of fetal alcohol syndrome. Spong, C.Y., Abebe, D.T., Gozes, I., Brenneman, D.E., Hill, J.M. J. Pharmacol. Exp. Ther. (2001)
- Management of isoimmunization in the presence of multiple maternal antibodies. Spong, C.Y., Porter, A.E., Queenan, J.T. Am. J. Obstet. Gynecol. (2001)
- Preterm premature rupture of the fetal membranes complicated by oligohydramnios. Spong, C.Y. Clin. Perinatol (2001)
- Maternal estrogen receptor-beta expression during mouse gestation. Spong, C.Y., McCune, S.K., Sternberg, E.M., Gustafsson, J.A. Am. J. Reprod. Immunol. (2000)









